ES2009924A6 - Procedimiento para preparar nuevos tetrahidrofuranos y tetrahidrotiofenos. - Google Patents

Procedimiento para preparar nuevos tetrahidrofuranos y tetrahidrotiofenos.

Info

Publication number
ES2009924A6
ES2009924A6 ES8801674A ES8801674A ES2009924A6 ES 2009924 A6 ES2009924 A6 ES 2009924A6 ES 8801674 A ES8801674 A ES 8801674A ES 8801674 A ES8801674 A ES 8801674A ES 2009924 A6 ES2009924 A6 ES 2009924A6
Authority
ES
Spain
Prior art keywords
tetrahydrothiophenes
tetrahydrofurans
ammonio
omega
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8801674A
Other languages
English (en)
Spanish (es)
Inventor
Jean-Jacques Godfroid
Francoise Heymans
Pierre Braquet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Publication of ES2009924A6 publication Critical patent/ES2009924A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES8801674A 1987-05-29 1988-05-27 Procedimiento para preparar nuevos tetrahidrofuranos y tetrahidrotiofenos. Expired ES2009924A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878712693A GB8712693D0 (en) 1987-05-29 1987-05-29 Tetrahydrofurans etc

Publications (1)

Publication Number Publication Date
ES2009924A6 true ES2009924A6 (es) 1989-10-16

Family

ID=10618139

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8801674A Expired ES2009924A6 (es) 1987-05-29 1988-05-27 Procedimiento para preparar nuevos tetrahidrofuranos y tetrahidrotiofenos.

Country Status (32)

Country Link
US (1) US5017588A (en])
JP (1) JPH0631228B2 (en])
KR (1) KR960005152B1 (en])
AR (1) AR243885A1 (en])
AT (1) AT395715B (en])
AU (1) AU610789B2 (en])
BE (1) BE1002146A3 (en])
CA (1) CA1317959C (en])
CH (1) CH674985A5 (en])
DE (1) DE3818106A1 (en])
DK (1) DK167532B1 (en])
ES (1) ES2009924A6 (en])
FI (1) FI89353C (en])
FR (2) FR2615854B1 (en])
GB (2) GB8712693D0 (en])
GR (1) GR1000147B (en])
HK (1) HK101790A (en])
IE (1) IE61341B1 (en])
IN (1) IN168799B (en])
IT (1) IT1219698B (en])
LU (1) LU87229A1 (en])
MA (1) MA21289A1 (en])
MY (1) MY103289A (en])
NL (1) NL192203C (en])
NO (1) NO170086C (en])
NZ (1) NZ224775A (en])
OA (1) OA08878A (en])
PT (1) PT87585B (en])
SE (1) SE466449B (en])
SG (1) SG93790G (en])
TN (1) TNSN88049A1 (en])
ZA (1) ZA883731B (en])

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8701727D0 (en) * 1987-01-27 1987-03-04 Scras Tetrahydrofuran derivatives
GB8712694D0 (en) * 1987-05-29 1987-07-01 Scras Tetrahydrofurans etc
ES2010568A6 (es) * 1988-08-04 1989-11-16 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 2,5-disustituidos de tetrahidrofurano.
ES2013834A6 (es) * 1989-01-30 1990-06-01 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 4-sustituidos de 2-alcoxitetrahidrofurano.
US5118708A (en) * 1989-06-23 1992-06-02 Norwich Eaton Pharmaceuticals, Inc. Use of 5-phenyl-2-furan esters, amides and ketones as neuroprotective agents
US20110097352A9 (en) * 1992-01-29 2011-04-28 Pharmexa Inc. Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
KR100326276B1 (ko) * 1999-12-14 2002-03-08 정명식 테트라하이드로푸란 유도체, 이의 제조방법 및 이를포함하는 항진균제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1088880A (en) * 1964-11-18 1967-10-25 Vantorex Ltd ª‡-cycloalkyleneimino-substituted esters
GB8701727D0 (en) * 1987-01-27 1987-03-04 Scras Tetrahydrofuran derivatives
GB8712694D0 (en) * 1987-05-29 1987-07-01 Scras Tetrahydrofurans etc

Also Published As

Publication number Publication date
AU610789B2 (en) 1991-05-23
NL192203C (nl) 1997-03-04
IE881599L (en) 1988-11-29
FR2615854A1 (fr) 1988-12-02
NO170086C (no) 1992-09-09
DE3818106A1 (de) 1988-12-15
US5017588A (en) 1991-05-21
LU87229A1 (fr) 1988-12-13
KR880013928A (ko) 1988-12-22
CH674985A5 (en]) 1990-08-15
NO170086B (no) 1992-06-01
SE8801964D0 (sv) 1988-05-26
CA1317959C (en) 1993-05-18
AR243885A1 (es) 1993-09-30
FI882475L (fi) 1988-11-30
GB2205100A (en) 1988-11-30
FR2615854B1 (fr) 1990-12-28
GR880100342A (en) 1989-02-23
NL8801315A (nl) 1988-12-16
FR2615735B1 (fr) 1991-01-11
FR2615735A1 (fr) 1988-12-02
PT87585A (pt) 1989-05-31
IT8820773A0 (it) 1988-05-27
GB8812488D0 (en) 1988-06-29
ATA140788A (de) 1992-07-15
JPH0631228B2 (ja) 1994-04-27
NZ224775A (en) 1990-01-29
ZA883731B (en) 1989-02-22
DK291088D0 (da) 1988-05-27
NO882335D0 (no) 1988-05-27
MY103289A (en) 1993-05-29
FI89353B (fi) 1993-06-15
OA08878A (fr) 1989-10-31
IE61341B1 (en) 1994-11-02
MA21289A1 (fr) 1988-12-31
NL192203B (nl) 1996-11-01
SG93790G (en) 1991-01-18
SE8801964L (sv) 1988-11-30
IN168799B (en]) 1991-06-08
DK291088A (da) 1988-11-30
AT395715B (de) 1993-02-25
TNSN88049A1 (fr) 1990-07-10
KR960005152B1 (ko) 1996-04-22
FI882475A0 (fi) 1988-05-26
SE466449B (sv) 1992-02-17
NO882335L (no) 1988-11-30
DK167532B1 (da) 1993-11-15
GR1000147B (el) 1991-09-27
BE1002146A3 (fr) 1990-07-31
JPS649988A (en) 1989-01-13
GB2205100B (en) 1990-08-15
DE3818106C2 (en]) 1993-07-01
AU1672288A (en) 1988-12-01
HK101790A (en) 1990-12-14
IT1219698B (it) 1990-05-24
PT87585B (pt) 1992-09-30
FI89353C (fi) 1993-09-27
GB8712693D0 (en) 1987-07-01

Similar Documents

Publication Publication Date Title
ES8101077A1 (es) Procedimiento para preparar acidos 3-cefem-4-carboxilicos sustituidos en la posicion 7
ES2039278T3 (es) Procedimiento para preparar inhibidores de 5-alfa-reductasa de esteroides.
ES2142798T3 (es) Derivados de 3-amido pirazol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2013067A6 (es) Un procedimiento para producir un derivado de piperazina.
ES2078509T3 (es) Composiciones inhibidoras de la reaccion de maillard.
ES2009924A6 (es) Procedimiento para preparar nuevos tetrahidrofuranos y tetrahidrotiofenos.
ES8301885A1 (es) Procedimiento para la preparacion de derivados de ciclohexe-no
GB1386150A (en) 6-acylaminophenyl-4,5-dihydropyridazones
FR2401155A1 (fr) Complexes de cuivre, leur procede de preparation et leur utilisation comme antimycotiques
BG48333A3 (en) Method for preparing of 2, 2- dimethyl cyclopropane carbonic acid derivatives
ES459297A1 (es) Procedimiento para la preparacion de antraquinon-bis-amidi- nas.
FR2450837A1 (fr) Acides penicillaniques 6-b-substitues inhibiteurs de b-lactamase, leur procede de production et composition pharmaceutique les contenant
JPS5566547A (en) Alkene derivative*its manufacture and medicine containing it and having sexial excitement control activity
DE3771057D1 (de) Platin enthaltender cytostatischer wirkstoff.
IT7849788A0 (it) Procedimento per produrre bis-dife nolcarbonati di poliesterdioli nonche' poliester-policarbonati ottenuti da essi
ES2074984T3 (es) Compuestos de 2-oxa-isocefem, composiciones que los contienen y procedimientos para su preparacion.
SE8001981L (sv) Kompositioner for behandling av glaukom
US3296068A (en) Omicron-and mu-allyloxyphenyl and mu-alkoxy-phenyl-nu-methyl carbamates and the insecticidal use thereof
IT7849767A0 (it) Procedimento per produrre bis-dife nolcarbonati di poliesterdioli nonche' poliester-policarbonati ottenuti da essi
SU603315A3 (ru) Композици дл контролировани количества насекомых
FR2382901A1 (en])
ES8604210A1 (es) Procedimiento para preparar 2- (fenetil) -5- (3,4-metilen- dioxi)-x-hidroxibencil) -pirrolidina
US2844503A (en) 1, 1-dimethyl-2, 2-di-(1-cyanoethyl) hydrazine, method of preparing, and compositions and method for controlling nematodes
BG28558A3 (bg) Фунгициден състав
US2844504A (en) 1, 1, 2-tri-(1-cyanoethyl) hydrazine, method of preparing, and compositions and methods for controlling nematodes